Skip to main content
. 2021 Dec 23;13:100287. doi: 10.1016/j.lanepe.2021.100287

Figure 1.

Figure 1

Serological response to infection by SARS-CoV-2 and vaccination with mRNA-1273 in people living with HIV.

SARS-CoV-2 anti-N total Ig at enrolment (A) and anti-S antibodies 28 days after completion of vaccination schedule (B) in people living with HIV. Comparison with healthy donors. Box and whiskers showing median values, 95% CIs and min to max. Statistics were calculated using Kruskal-Wallis test with Dunn's multiple comparisons test. Exact numbers of participants for each group are indicated in the corresponding results paragraph.

COI= Cut-Off Index; PLWHIV=people living with HIV; HDs=healthy donors.